Related Experiment Video
Updated: Sep 17, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Cepharanthine improves rheumatoid arthritis by regulating functions of fibroblast-like synoviocytes and macrophage
Bao Hou1, Mingtao Yang1, Haoting Liu1
1MOE Medical Basic Research Innovation Center for Gut Microbiota and Chronic Diseases, School of Medicine, Jiangnan University, Wuxi, 214122, China; Department of Basic Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi, 214122, China.
Abstract:
Rheumatoid arthritis (RA) is a chronic autoimmune disease featured by persistent synovial inflammation, progressive bone erosion, and cartilage destruction. Although conventional treatments relieve clinical symptoms, their long-term application is frequently limited by severe side effects. Cepharanthine, a natural alkaloid, possesses potent anti-inflammatory properties, yet its therapeutic effects and precise mechanisms against RA remain largely unclear. This study aimed to evaluate the therapeutic potential of cepharanthine in RA and explore the underlying molecular basis. The effects of cepharanthine were evaluated in interleukin-1 (IL-1) receptor antagonist-deficient (IL1-RA-/-) mice in vivo, and in fibroblast-like synoviocytes (FLS) and RAW264.7 macrophages in vitro. In vivo, cepharanthine significantly decreased the arthritis index and paw swelling, preserved bone microstructure, attenuated synovial hyperplasia and inflammatory infiltration, and mitigated cartilage degeneration in IL1RA-/- mice. In vitro, cepharanthine showed no obvious cytotoxicity at concentrations from 1 nM to 100 μM. Cepharanthine inhibited inflammation, proliferation, and migration of FLS. Meanwhile, cepharanthine promoted the phenotypic shift of macrophages from pro-inflammatory M1 toward anti-inflammatory M2. Transcriptomic profiling and bioinformatics analysis revealed the advanced glycation end products (AGE)-receptor for advanced glycation end products (RAGE) signaling pathway as a key target of cepharanthine. Collectively, cepharanthine mitigates joint inflammation and structural damage in RA by inhibiting the AGE/RAGE/rat sarcoma viral oncogene homolog (Ras)/nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB) signaling cascade. Overall, cepharanthine serves as a promising natural candidate for the treatment of RA. This study also provides a novel rationale for developing plant-derived agents against autoimmune arthritis.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
The JAK-STAT Signaling Pathway
Chronic Inflammation: Introduction
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...